Recognition of impairment loss on investment securities
First written in FY2019-Q2. 2 of 12 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2017: 8 of 23 companies on the "Worse" side.
- FY2026-H1DroppedAnnual report
「Impairment losses on investment securities 1 －」
The ¥1 million valuation loss on investment securities recognized in the same period of the previous year was not recognized in the current interim period. - FY2025Impairment losses on investment securities recognized againAnnual report
「An impairment loss of ¥1 million was recognized on securities during the current consolidated fiscal year.」
For investment securities, which had no impairment loss in the previous fiscal year, an impairment loss of ¥1 million was recognized in the current fiscal year. - FY2024DroppedAnnual report
「None.」
The company states that no securities were subject to impairment losses during the current fiscal year. - FY2022Updated the annual valuation loss amountAnnual report
「Impairment losses of ¥13 million in the previous consolidated fiscal year and ¥2 million in the current consolidated fiscal year were recognized on securities.」
The impairment loss on securities for the current fiscal year has been finalized and disclosed at ¥2 million. - FY2021Updated the annual valuation loss amountAnnual report
「Impairment losses of ¥3 million in the previous consolidated fiscal year and ¥13 million in the current consolidated fiscal year were recognized on securities.」
The impairment loss on investment securities and other securities has been finalized and disclosed at ¥13 million for the current fiscal year. - FY2021-Q3Updated the valuation loss amountAnnual report
「Valuation loss on investment securities 13,290」
The valuation loss on investment securities for the cumulative third-quarter period is disclosed at ¥13.290 million. - FY2021-Q2Updated the valuation loss amountAnnual report
「Valuation loss on investment securities 3,999」
The valuation loss on investment securities for the cumulative second-quarter period is disclosed at ¥3.999 million. - FY2020Updated the annual valuation loss amountAnnual report
「Impairment losses of ¥281.073 million in the previous consolidated fiscal year and ¥3.754 million in the current consolidated fiscal year were recognized on securities.」
The full-year impairment loss on investment securities, including the valuation loss disclosed in the first quarter, has been finalized and disclosed at ¥3.754 million. - FY2020-Q1Additional disclosure of the impairment loss for the first quarterAnnual report
「Valuation loss on investment securities 1,985」
The quarterly consolidated income statement discloses a valuation loss on investment securities of ¥1.985 million for the first quarter. - FY2019RestatedAnnual report
「Impairment losses of ¥15,981 thousand in the previous fiscal year and ¥281,073 thousand in the current fiscal year were recognized on securities.」
The recognition of the ¥281,073 thousand impairment loss on investment securities was reconfirmed in the annual results. - FY2019-Q3RestatedAnnual report
「Impairment loss on investment securities 281,073」
The quarterly consolidated income statement continues to disclose the recognition of an impairment loss on investment securities of ¥281 million as an extraordinary loss. - FY2019-Q2First statedAnnual report
「During the six-month period, an impairment loss on investment securities of ¥281 million was recognized as an extraordinary loss.」
The disclosure states for the first time that an impairment loss on investment securities of ¥281 million was recognized as an extraordinary loss during the six-month period.